Companies
Acquired by KnowBe4
Acquired by Apple
Acquired by Capital D
Acquired by Oracle
Acquired by Siemens
Acquired by ERT Inc
IPO: AREC
IPO: ORTX
IPO: FRLN
IPO: ACHL
IPO: MGTX
Acquired by Facebook
IPO: BKNG
Acquired by Anthropic
Explore our investments
-
Frontiers Strategy investments
-
Established2016In collaboration with UCL Business
-
Total investment> $2bnOver $2bn of follow on funding for portfolio
-
Public offerings4 IPOsFour NASDAQ IPOs since 2018
Featured investments
Oriole to deploy world’s first AI system to supercharge data centers
Oriole to deploy world’s first AI system to supercharge data centers
EpilepsyGTx raises $33m Series A to develop single dose gene therapy for focal refractory epilepsy
Companies
-
Achilles TherapeuticsBiopharmaceutical company developing precision T cell therapies
Frontiers StrategyIPO -
Apollo Therapeuticsbiopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs Frontiers StrategyGrowth
-
Axovia TherapeuticsGene therapy company developing disease-transformative medicines for ciliopathies Frontiers StrategyExited
-
Bloomsbury AIEnabling everyone to easily create their own question-answering system Frontiers StrategyExited
-
Bloomsbury GTXBiotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases Frontiers StrategyExited
-
Bramble EnergyFuel cell company on a mission to help the world achieve net zero Frontiers StrategyExited
-
Echopoint MedicalTransforming interventional cardiology with optical-fibre based sensors Frontiers StrategyGrowth
-
EpilepsyGTxBiotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy Frontiers StrategyEarly Stage
-
EpsilogenImmuno-oncology company targeting cancer with the IgE class of antibodies Frontiers StrategyEarly Stage
-
FreelineBiopharmaceutical company focused on the development of liver-directed gene therapies Frontiers StrategyIPO
-
GaussionRevolutionising batteries through magneto-electrochemistry: MagLiB technology. Frontiers StrategyGrowth
-
HazySynthetic data platform Frontiers StrategyExited
-
HumanloopSoftware development company that helps businesses build and test AI applications based on large language models (LLMs) Frontiers StrategyExited
-
IntrinsicDeveloping a new type of all silicon non-volatile memory Frontiers StrategyGrowth
-
Meira GTXVertically integrated, clinical stage gene therapy company Frontiers StrategyIPO
-
NovalGenImmuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer Frontiers StrategyEarly Stage
-
Nozzle.aiAI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers Frontiers StrategyExited
-
Odin VisionBuilds a new era of cloud connected endoscopy Frontiers StrategyExited
-
Orchard TherapeuticsBiotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases Frontiers StrategyIPO
-
OrioleUCL spinout using light to train LLMs a hundred times faster with only a fraction of power Frontiers StrategyGrowth
-
PhasecraftUsing disruptive theory to unlock the power of quantum computing Frontiers StrategyGrowth
-
PometrySoftware company simplifying graph analytics for businesses Frontiers StrategyEarly Stage
-
Quell TherapeuticsA clinical stage company transforming lives in immune mediated disease Frontiers StrategyGrowth
-
Senya TxTargeting LRG1 as a pathological regulator in a range of vascular diseases Frontiers StrategyEarly Stage
-
Stanhope AIAI startup leveraging active inference and the free energy principle to build ‘Agentic AI’ for the real world. Frontiers StrategyEarly Stage
-
Third Space LearningEdTech platform connecting tutors in the developing countries to students in developed economies Frontiers StrategyEarly Stage
